Chief Global Strategy Officer at Genome Canada
Dr. Lopez-Correa is the Chief Global Strategy Officer (CGSO) at Genome Canada. As CGSO, she is taking genomics to the next level in Canada, by advancing mission driven initiatives using genomics to solve the most pressing global challenges. Dr. Lopez-Correa holds an MD from the Universidad Pontificia Bolivariana in Colombia, an MSc in Human Genetics from Paris V University in France, a PhD in Medical Sciences from the KULeuven in Belgium, and a mini-MBA from McGill University in Canada.
Prior to that, she was Executive Director of the Canadian COVID19 Genomics Network (CanCOGeN) and CSO at Genome Canada, COO at Ruta N Medellin, CSO at Genome BC, and at Genome Quebec. Dr. Lopez-Correa has also held leadership positions at deCODE Genetics, and Eli Lilly and has played advisory roles at the European Commission, Innovative Medicine Initiatives and other private and public sector entities working in the application and implementation of genomics technologies. As part of her commitment to international development, Dr. Lopez-Correa has led several initiatives aimed at demonstrating the impact of genomics and innovation in developing countries. As a breast cancer patient herself, Dr. Lopez-Correa has been a strong advocate for the use of genomics to improve diagnosis and treatment of cancer patients.
